AdvertiseDonate
LatestDemocrats Seize Congress and State Power in Historic Midterm Sweep
MemphisTulsaMcKinneyGarlandPlanoFriscoSt. LouisDallas
Thursday, November 5, 2026Today’s news, without the noise.
Hot Perspective · 301 President Clinton Avenue B, Little Rock, AR 72201

Warhound Targets 2027 for First Genetically Edited Military Dogs

The startup secured $200 million to clone elite service canines, focusing initially on reducing breed-specific health issues like hip dysplasia.

By Noor Rossi ·

Illustration for: Warhound Targets 2027 for First Genetically Edited Military Dogs
Illustration generated for this article, not a news photograph.

Warhound, a new venture backed by $200 million in funding, projects that its first batch of genetically engineered dogs will arrive in early 2027. The company intends to use these animals for standard military tasks, including bomb detection and search-and-rescue operations. This timeline marks the initial phase of a project designed to produce canines with optimized genetic traits.

The biological foundation for the project comes from cell samples collected from high-performing working dogs. These donors include Belgian Malinois, as well as labradors and shepherdes, selected from military, police, and first-responder units across the United States. Scientists at Colossal Biosciences are currently editing the DNA of these samples. Their immediate goal is to clone the animals while reducing the likelihood of common health issues such as hip dysplasia and specific cancers.

Ben Lamm, co-founder of Colossal Biosciences, told Wired that the team has already begun the gene-editing process. He indicated to TechCrunch that future modifications could target physical capabilities, potentially making the dogs faster, more agile, or equipped with a sharper sense of smell. The company plans to layer these enhancements after establishing a baseline for improved health.

Palmer Luckey, the founder of Anduril and Oculus VR, is a partner in the venture. However, neither Luckey nor Anduril holds an equity stake in Warhound. Colossal Biosciences does hold equity, and Lamm serves on the board. David Spirk, formerly of Palantir, acts as the chief executive officer. This structure separates the biological development from the hardware integration.

Anduril’s involvement centers on the technology the dogs will wear rather than their internal biology. The company will design protective equipment and the software that controls it. Planned items include goggles, vests, and body armor. Luckey’s firm previously partnered with OpenAI to develop artificial intelligence for the Pentagon and has secured a US Army contract to build a next-generation battlefield intelligence system with Palantir.

The project blends Lamm’s experience in de-extinction efforts, such as the dire wolf and woolly mammoth initiatives, with Luckey’s defense technology background. While the partnership involves two high-profile figures, the operational focus remains on creating a reliable supply of healthy, high-performing working dogs. The first clones are expected to be born within the next few months, beginning the transition from laboratory research to active service.

Source: Engadget

More Tech · Report a business · Got a Story?

Get Hot Perspective in your inboxToday’s news, without the noise. Free, a few times a week, unsubscribe any time.

Related stories

Get Hot Perspective in your inboxToday’s news, without the noise. Free, a few times a week, unsubscribe any time.